← Back
Data updated: Mar 29, 2026
CHENGDU
OncologyOphthalmologyMetabolic
Generics
CHENGDU is a generic drug manufacturer focused on Oncology, Ophthalmology, Metabolic.
2024
Since
1
Drugs
-
Trials
25
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 53%
0 drugs Phase 3: 3 Phase 2: 2 Phase 1: 16
Ophthalmology 33%
0 drugs Phase 3: 4 Phase 1: 4
Metabolic 7%
0 drugs Phase 3: 1
Dermatology 3%
0 drugs Phase 2: 1
Infectious Disease 3%
0 drugs Phase 2: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Baxter specialty
Infectious Disease, Oncology, Dermatology, Ophthalmology
Bayer big-pharma
Oncology, Ophthalmology, Dermatology, Metabolic
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Metabolic
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology, Metabolic
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-01-25
- Latest
- 2025-09-04
- Applications
- 1